B

Brooks Automation Inc
LSE:0HQ1

Watchlist Manager
Brooks Automation Inc
LSE:0HQ1
Watchlist
Price: 46.1642 USD 5.66% Market Closed
Market Cap: 409B USD
Have any thoughts about
Brooks Automation Inc?
Write Note

Brooks Automation Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Brooks Automation Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Brooks Automation Inc
LSE:0HQ1
Total Liabilities & Equity
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
10%
KLA Corp
NASDAQ:KLAC
Total Liabilities & Equity
$15.7B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
11%
Applied Materials Inc
NASDAQ:AMAT
Total Liabilities & Equity
$34.4B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
10%
Entegris Inc
NASDAQ:ENTG
Total Liabilities & Equity
$8.5B
CAGR 3-Years
41%
CAGR 5-Years
28%
CAGR 10-Years
17%
Lam Research Corp
NASDAQ:LRCX
Total Liabilities & Equity
$19.5B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
9%
Teradyne Inc
NASDAQ:TER
Total Liabilities & Equity
$3.8B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
3%
No Stocks Found

Brooks Automation Inc
Glance View

Market Cap
409B USD
Industry
Semiconductors

Brooks Automation Inc. has established itself as a pivotal player in the automation and semiconductor industries, positioning itself at the heart of the technology supply chain. The company’s core operations revolve around two primary segments: Semiconductor Solutions and Life Sciences. In the Semiconductor Solutions division, Brooks develops sophisticated technology and systems that enhance wafer fabrication and streamline production processes, crucial for ensuring the efficiency of semiconductor manufacturers. Meanwhile, the Life Sciences segment focuses on advanced laboratory automation and sample management solutions, catering to biopharmaceutical companies and research institutions. This dual-focus allows Brooks to tap into rapidly growing markets, particularly as the global demand for semiconductor components surges and the life sciences sector continues to expand due to increased investment in research and development. For investors, Brooks Automation presents a compelling opportunity rooted in its robust financial performance and strategic positioning. A commitment to innovation and quality is reflected in the company's ongoing investment in research and development, which drives new technologies and enhances existing products. Moreover, Brooks has demonstrated a consistent ability to generate strong revenues and profits, coupled with a solid balance sheet that underscores financial stability. As industries increasingly embrace automation and digital transformation, Brooks is poised to leverage its expertise and market knowledge to capitalize on these trends. With its increasing focus on sustainability and efficiency, Brooks Automation stands as a potential growth story that aligns well with long-term investment strategies, making it an attractive consideration for investors looking to tap into the future of technology and healthcare.

0HQ1 Intrinsic Value
0.4618 USD
Overvaluation 99%
Intrinsic Value
Price
B

See Also

What is Brooks Automation Inc's Total Liabilities & Equity?
Total Liabilities & Equity
2.1B USD

Based on the financial report for Sep 30, 2024, Brooks Automation Inc's Total Liabilities & Equity amounts to 2.1B USD.

What is Brooks Automation Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
10%

Over the last year, the Total Liabilities & Equity growth was -27%. The average annual Total Liabilities & Equity growth rates for Brooks Automation Inc have been 5% over the past three years , 7% over the past five years , and 10% over the past ten years .

Back to Top